Localised rhabdomyosarcoma in infants (<12 months) and young children (12–36 months of age) treated on the EpSSG RMS 2005 study

International incidence of childhood cancer, 2001–10: a population-based registry study

Eva Steliarova‐Foucher, Murielle Colombet, Lynn A. G. Ries et al. · The Lancet Oncology · 2017 · 1.8K citations · Full text

Medicine, Oncology, Pediatrics +17

Analysis of Prognostic Factors in Patients With Nonmetastatic Rhabdomyosarcoma Treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children's Oncology Group

Jane L. Meza, James R. Anderson, Alberto S. Pappo et al. · Journal of Clinical Oncology · 2006 · 392 citations · Full text

Medicine, Oncology, Surgery +16

A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma

Rita Alaggio, Lei Zhang, Yun‐Shao Sung et al. · The American Journal of Surgical Pathology · 2015 · 281 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Age is an independent prognostic factor in rhabdomyosarcoma: A report from the soft tissue sarcoma committee of the children's oncology group

Devendra Joshi, James R. Anderson, Charles N. Paidas et al. · Pediatric Blood & Cancer · 2003 · 235 citations

Medicine, Oncology, Pediatrics +13

Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Embryonal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group

R. Beverly Raney, David Walterhouse, Jane L. Meza et al. · Journal of Clinical Oncology · 2011 · 226 citations · Full text

Medicine, Oncology, Radiation Oncology +17